Teleflex Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript

Mar 23, 2022 / 01:45PM GMT
Matthew Ian Mishan - KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research Analyst

Good morning. I'd like to welcome everyone to the second day of the KeyBank Life Sciences & MedTech Investor Forum. My name is Matt Mishan. I'm our senior med tech analyst, and I'm pleased to be joined by Teleflex, who is represented today by Thomas Powell, EVP and CFO; and Larry Keusch, VP of IR and Strategy Development.

For the audience, I'll start us off. (Operator Instructions) Tom, Larry, thank you very much for joining us.

Questions and Answers:

Matthew Ian Mishan - KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research Analyst

I'll start off with a macro question to start. I believe there's just a lot of disconnected moving pieces right now, and it's hard to see the bigger picture, which is a challenge. And just to level set, what's most important for your business from a macro perspective? And kind of where is management spending the most time at this point?

Thomas E. Powell
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot